As drug makers prepare to make a killing on supposed vaccines against COVID-19, it is important, particularly for those who consider vaccines to be a wise investment today, or those whose retirement savings might get invested in such vaccines without their knowledge, to reflect on the fact that corporations are themselves viruses that can only […]
In June the World Health Organization (WHO) published a new classification of antibiotics aimed at fighting drug resistance, with penicillin-type drugs recommended as the first line of defense, and others only when absolutely necessary. [1]
The World Health Organization (WHO) is warning that antibiotic-resistant strains of gonorrhea are on the rise, and about 78 million people per year could be at risk for the sexually-transmitted disease (STD). [1]
In a recent report, the WHO explains how researchers looked at data from gonorrhea cases and antibiotic resistance from 77 countries. Of those countries:
Gonorrhea has long been a sexually transmitted disease that is treated with a strong dose of antibiotics. However, it may soon become untreatable as it develops resistance to the two antibiotics left that can treat it: azithromycin and ceftriaxon.
CBS News reports that antibiotic resistant strains of this STD have more than quadrupled in the United States.
